Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Midatech Pharma PLC | MTP | NASDAQ | Depository Receipt |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.2851 | 0.2851 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 0.2851 | USD |
Midatech Pharma PLC Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.98M | - | - | - | 1.90 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Midatech Pharma
Date | Time | Source | Heading |
---|---|---|---|
6/13/2024 | 08:48 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
6/06/2024 | 15:05 | Edgar (US Regulatory) | Form F-1 - Registration statement for certain foreign.. |
5/29/2024 | 08:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/29/2024 | 08:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/29/2024 | 08:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/28/2024 | 16:03 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
5/22/2024 | 15:06 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/22/2024 | 15:04 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/22/2024 | 09:21 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/22/2024 | 09:16 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/22/2024 | 09:14 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/22/2024 | 09:10 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
MTP Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas. The company has only one operating segment Pipeline Research and Development. The research and development activities involve the discovery and development of pharmaceutical products in the field of nanomedicine and sustained release technology. |